Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

Sabine Vogler () and Kenneth R. Paterson
Additional contact information
Sabine Vogler: Gesundheit Österreich GmbH (GÖG/Austrian Public Health Institute)
Kenneth R. Paterson: University of Glasgow

PharmacoEconomics - Open, 2017, vol. 1, issue 3, No 1, 145-147

Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
http://link.springer.com/10.1007/s41669-017-0028-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-017-0028-1

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().